NewsBenzingaTakeda Pharmaceutical: EPS rettificato del Q2 a 0,48 dollari batte la stima di 0,31 dollari, ricavi a 7,457 miliardi di dollari battono la stima di 7,190 miliardi di dollari Takeda Pharmaceutical: EPS rettificato del Q2 a 0,48 dollari batte la stima di 0,31 dollari, ricavi a 7,457 miliardi di dollari battono la stima di 7,190 miliardi di dollari Benzinga 2026.10.29 07:57 (GMT+0) Open on Benzinga Other news Ardent Health Stock Tumbles 14.61% After Hours: Here's Why Lowe's Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts Elon Musk Had a Facepalm Moment After Sean Duffy Defends Rejecting Free Starlink for FAA: ‘Our Airspace Is Very Big’ Iridex (NASDAQ: IRIX) Shares Fall 26.96% After Hours: What Investors Should Know ‘The Noise Will Work Itself Out in Time’: AMD CEO Lisa Su Says Nvidia a ‘Phenomenal Company’ After Jensen Huang Exits Morning Bid: Jensen Huang's last hurrah, and a nervy future for Nvidia
Lowe's Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Elon Musk Had a Facepalm Moment After Sean Duffy Defends Rejecting Free Starlink for FAA: ‘Our Airspace Is Very Big’
‘The Noise Will Work Itself Out in Time’: AMD CEO Lisa Su Says Nvidia a ‘Phenomenal Company’ After Jensen Huang Exits